Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,710.00
-70.00 (-1.21%)
Feb 21, 2025, 9:00 AM KST

Kwang Dong Pharmaceutical Revenue

Kwang Dong Pharmaceutical had revenue of 424.59B KRW in the quarter ending September 30, 2024, with 6.72% growth. This brings the company's revenue in the last twelve months to 1.63T, up 8.23% year-over-year. In the year 2023, Kwang Dong Pharmaceutical had annual revenue of 1.51T with 5.79% growth.

Revenue (ttm)
1,634.20B
Revenue Growth
+8.23%
P/S Ratio
0.14
Revenue / Employee
1.57B
Employees
1,042
Market Cap
224.29B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231,514.45B82.91B5.79%
Dec 31, 20221,431.55B93.36B6.98%
Dec 31, 20211,338.18B94.41B7.59%
Dec 31, 20201,243.77B5.51B0.45%
Dec 31, 20191,238.25B58.03B4.92%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
KT&G Corporation 5,793.78B
Amorepacific 3,719.46B
Samyang Foods 1,575.91B
LG H&H 6,769.21B
ORION 3,010.89B
CJ Cheiljedang 29.16T
Dong Suh Companies 479.36B
E-MART 29.13T
Revenue Rankings